1. Home
  2. MBUU vs VOR Comparison

MBUU vs VOR Comparison

Compare MBUU & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Malibu Boats Inc.

MBUU

Malibu Boats Inc.

HOLD

Current Price

$26.22

Market Cap

474.0M

Sector

Industrials

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$16.05

Market Cap

755.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBUU
VOR
Founded
1982
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
474.0M
755.7M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
MBUU
VOR
Price
$26.22
$16.05
Analyst Decision
Hold
Buy
Analyst Count
7
10
Target Price
$32.43
$45.44
AVG Volume (30 Days)
275.7K
1.2M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
127.74
N/A
EPS
N/A
N/A
Revenue
$807,561,000.00
N/A
Revenue This Year
$1.44
N/A
Revenue Next Year
$10.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.92
$0.13
52 Week High
$39.65
$49.95

Technical Indicators

Market Signals
Indicator
MBUU
VOR
Relative Strength Index (RSI) 50.81 55.16
Support Level $24.30 $11.38
Resistance Level $27.81 $16.88
Average True Range (ATR) 1.01 1.63
MACD 0.23 0.05
Stochastic Oscillator 66.67 50.81

Price Performance

Historical Comparison
MBUU
VOR

About MBUU Malibu Boats Inc.

Malibu Boats is a designer and manufacturer of power boats in the United States. It is a market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a producer of sterndrive boats, in 2017, and Pursuit Boats, which makes high end offshore and outboard motorboats in 2018. In 2021, it purchased Maverick Boat Group, a seller of flat fishing boats, with exposure to bay, dual console, and center console boats. Malibu has also expanded into boat trailers and accessories, and in 2020, began producing its own engines for its performance sport boats.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: